Ad is loading...
AEMD
Price
$0.40
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
GNGBY
Price
$16.40
Change
-$0.45 (-2.67%)
Updated
Nov 15 closing price
Ad is loading...

AEMD vs GNGBY

Header iconAEMD vs GNGBY Comparison
Open Charts AEMD vs GNGBYBanner chart's image
Aethlon Medical
Price$0.40
Change-$0.00 (-0.00%)
Volume$555.19K
CapitalizationN/A
Getinge AB
Price$16.40
Change-$0.45 (-2.67%)
Volume$78.67K
CapitalizationN/A
AEMD vs GNGBY Comparison Chart
Loading...
AEMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GNGBY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AEMD vs. GNGBY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEMD is a Sell and GNGBY is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (AEMD: $0.40 vs. GNGBY: $16.40)
Brand notoriety: AEMD and GNGBY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AEMD: 76% vs. GNGBY: 452%
Market capitalization -- AEMD: $4.4M vs. GNGBY: $5.07B
AEMD [@Medical Specialties] is valued at $4.4M. GNGBY’s [@Medical Specialties] market capitalization is $5.07B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEMD’s FA Score shows that 1 FA rating(s) are green whileGNGBY’s FA Score has 1 green FA rating(s).

  • AEMD’s FA Score: 1 green, 4 red.
  • GNGBY’s FA Score: 1 green, 4 red.
According to our system of comparison, GNGBY is a better buy in the long-term than AEMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEMD’s TA Score shows that 6 TA indicator(s) are bullish while GNGBY’s TA Score has 4 bullish TA indicator(s).

  • AEMD’s TA Score: 6 bullish, 3 bearish.
  • GNGBY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AEMD is a better buy in the short-term than GNGBY.

Price Growth

AEMD (@Medical Specialties) experienced а -0.92% price change this week, while GNGBY (@Medical Specialties) price change was -8.51% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

AEMD is expected to report earnings on Feb 14, 2024.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNGBY($5.07B) has a higher market cap than AEMD($4.4M). GNGBY YTD gains are higher at: -24.820 vs. AEMD (-81.767). GNGBY has higher annual earnings (EBITDA): 5.41B vs. AEMD (-12.28M). GNGBY has more cash in the bank: 4.43B vs. AEMD (7.97M). AEMD has less debt than GNGBY: AEMD (1.01M) vs GNGBY (6.89B). GNGBY has higher revenues than AEMD: GNGBY (29.8B) vs AEMD (574K).
AEMDGNGBYAEMD / GNGBY
Capitalization4.4M5.07B0%
EBITDA-12.28M5.41B-0%
Gain YTD-81.767-24.820329%
P/E RatioN/A24.88-
Revenue574K29.8B0%
Total Cash7.97M4.43B0%
Total Debt1.01M6.89B0%
FUNDAMENTALS RATINGS
AEMD vs GNGBY: Fundamental Ratings
AEMD
GNGBY
OUTLOOK RATING
1..100
4550
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
6
Undervalued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9779
PRICE GROWTH RATING
1..100
6280
P/E GROWTH RATING
1..100
10049
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNGBY's Valuation (6) in the null industry is in the same range as AEMD (28) in the Medical Specialties industry. This means that GNGBY’s stock grew similarly to AEMD’s over the last 12 months.

GNGBY's Profit vs Risk Rating (93) in the null industry is in the same range as AEMD (100) in the Medical Specialties industry. This means that GNGBY’s stock grew similarly to AEMD’s over the last 12 months.

GNGBY's SMR Rating (79) in the null industry is in the same range as AEMD (97) in the Medical Specialties industry. This means that GNGBY’s stock grew similarly to AEMD’s over the last 12 months.

AEMD's Price Growth Rating (62) in the Medical Specialties industry is in the same range as GNGBY (80) in the null industry. This means that AEMD’s stock grew similarly to GNGBY’s over the last 12 months.

GNGBY's P/E Growth Rating (49) in the null industry is somewhat better than the same rating for AEMD (100) in the Medical Specialties industry. This means that GNGBY’s stock grew somewhat faster than AEMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AEMDGNGBY
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 10 days ago
68%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 3 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
70%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
62%
View a ticker or compare two or three
Ad is loading...
AEMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GNGBY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDD2.970.13
+4.58%
3D Systems Corp
TGLS73.17-0.77
-1.04%
Tecnoglass
FTI28.18-0.31
-1.09%
TechnipFMC plc
WMPN12.97-0.26
-1.97%
William Penn Bancorporation
FFIE1.26-0.12
-8.70%
Faraday Future Intelligent Electric Inc

AEMD and

Correlation & Price change

A.I.dvisor tells us that AEMD and CODX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AEMD and CODX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEMD
1D Price
Change %
AEMD100%
+0.20%
CODX - AEMD
30%
Poorly correlated
-3.64%
GNGBY - AEMD
26%
Poorly correlated
-2.67%
IDXX - AEMD
25%
Poorly correlated
-0.65%
CSTL - AEMD
25%
Poorly correlated
-8.86%
RBOT - AEMD
24%
Poorly correlated
-11.03%
More

GNGBY and

Correlation & Price change

A.I.dvisor tells us that GNGBY and CNMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNGBY and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNGBY
1D Price
Change %
GNGBY100%
-2.67%
CNMD - GNGBY
32%
Poorly correlated
+1.47%
ALGN - GNGBY
29%
Poorly correlated
+0.92%
AVNS - GNGBY
28%
Poorly correlated
-2.45%
SNN - GNGBY
27%
Poorly correlated
+1.01%
AEMD - GNGBY
26%
Poorly correlated
+0.20%
More